Quartesian Adopts OpenClinica for Electronic Data Capture

Share Article

Global data management CRO Quartesian announces is has selected OpenClinica as its Electronic Data Capture (EDC) solution for its clients' clinical trials.

We are thrilled to have Quartesian involved in the OpenClinica community

Quartesian, a multi-national Contract Research Organization specializing in data management, statistics, medical writing and eClinical technologies, announces it has selected OpenClinica as its Electronic Data Capture (EDC) solution for its clients' clinical trials.

Quartesian represents one of a growing number of contract research organizations turning to OpenClinica to manage their studies.

"We love the open source approach" said Benjamin Jackson, Quartesian President & CEO. "We have chosen OpenClinica as our EDC solution in part because it fits our current business need for low cost rapid implementation of EDC for Phase I trials. It also aligns with our strategy to bring our infrastructure and processes for data management in line with the current thinking of open source systems, data interoperability and the re-engineering of the clinical trial process."

OpenClinica's enterprise-quality architecture, robust feature set, and free open source license is appealing to CROs who are looking to standardize on an EDC solution. It can be deployed quickly and used cost effectively in clinical studies of all sizes and types. In addition, many CROs have modified OpenClinica's source code and integrated it with other internal systems to "make it their own."

Indeed, Quartesian's CEO sees OpenClinica as a key component to the firm's strategy. According to Jackson, "After we release our version of OpenClinica in the fourth quarter of 2008, we look forward to providing OpenClinica as our first solution for data capture and data management for clinical trials in oncology, human growth hormone, vaccines, urology, and repertory, and other areas."

"We are thrilled to have Quartesian involved in the OpenClinica community," said Paul Galvin, Product Manager at Akaza Research, the creators of OpenClinica. "The richness and breadth of OpenClinica's global community drives the product's quality and evolution."

About Quartesian

With offices in the United States, India, and Ukraine, Quartesian is a global Contract Research Organization specializing in data management, statistics, medical writing and eClinical technologies. Quartesian's business model is based on building the value chain of clinical trial services with other service providers. The company's structure allows it to provide tailored, personalized services to its clients while offering robust global resources and leading technology. The result is high quality time- and cost-efficient services with maximum flexibility and responsiveness. For more information see http://www.quartesian.com.

About OpenClinica®

OpenClinica is open source web-based electronic data capture software for clinical research. It facilitates protocol configuration, design of case report forms, clinical data capture, and study/data management. OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. All versions of OpenClinica are available for download at http://www.OpenClinica.org.

About Akaza Research®

Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data capture and management software platform. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for all types of clinical research. Akaza Research provides OpenClinica support, training, and consulting services to its customers worldwide. See http://www.akazaresearch.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ben Baumann

John Packianathan
Visit website